Categories: All postsAnalysts

Is Altus Group stock a buy?

Following a canceled acquisition, Eight Capital analyst Christian Sgro remains on the fence regarding Altus Group (Altus Group Stock Quote, Chart, News, Analysts, Financials TSX:AIF).

On April 17, Altus Group announced that it had canceled the proposed acquisition of Situs Group’s commercial real estate valuation service due to regulatory approval issues with the FTC.

“We are disappointed that we cannot move forward with a deal we believe would benefit all stakeholders, and contribute towards our efforts to bring greater consistency and transparency of valuations across the [commercial real estate] industry,” CEO Jim Hannon said. “This opportunity would have led to improved compliance reporting of valuations, and provided our clients and their investors with deeper insights on the performance of their CRE assets. Moving forward, Altus Group is strongly positioned to execute on our organic strategy to deliver best-in-class valuation intelligence to our clients.”

The analyst says the development, for him, was mixed.

“With difficulty obtaining regulatory approval, Altus terminated the proposed $250M+ acquisition of Situs Group’s valuation business,” he wrote. “This is a material strategic update, curbing Altus’ inorganic analytics expansion plans. With that said, we think the announcement is ultimately positive for shares today. This is because of Altus’ reduced pro forma debt load and renewed focus on organic priorities, including delivering against the 2024 financial outlook.”

In a research update to clients May 21, Sgro maintained his “Neutral” rating an price target of $50.00 on AIF.

The analyst thinks AIF will post Adjusted EBITDA of $164-million on revenue of $819-million in fiscal 2024. He expects those numbers will improve to Adjusted EBITDA of $208-million on a topline of $907-million in fiscal 2025.

Tagged with: aif
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

3 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

3 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

4 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

4 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

4 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

4 hours ago